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     Pheochromocytomas are tumors of the chromaffin cells, most commonly positioned on the adrenal 
medulla [8], although sometimes occur throughout the abdomen and thoracic regions, then known as 
paragangliomas [5].  Studies have indicated the majority of pheochromocytomas are idiopathic in nature, 
with one-fourth of diagnoses containing a genetic component.  Both are usually diagnosed between the 
ages of thirty-five and fifty [5].  It is estimated that a PCC is present in four to five percent of the 
hypertensive population.  They seem to occur equally between men and women [8].  They are challenging 
to diagnose, as they often appear dormant.  When active, excessive catecholamine release causes a 
variety of symptoms, with hypertension as the most prominent.   This hypertension occurs related to an 
increase in peripheral vascular resistance.  Stressors to the body, such as exercise, caffeine intake, and 
surgery often prompt the catecholamine surge.  Foods high in tyrosine, such as yogurt, wine and beer, can 
also spark  their catecholamine release [9].  Effects of this hypertension, such as cardiomyopathy and 
infarction have been seen [1].  Palpitations, anxiety, and heat intolerance can occur.  Fluctuation in blood 
levels of norepinephrine and epinephrine also lead to headaches and a potential decrease in cerebral 
blood flow [9].  One severe case has linked a PCC with a dissecting aneurysm of the vertebral artery [1].  
Metabolic increases lead to diaphoresis and otherwise unexplained weight loss.  Decreased insulin release 
can lead to hyperglycemia [9].  Because of the intermittent presentation of symptoms, As high as twenty-
one percent of pheochromocytomas are without symptoms, which can be related to the patient’s 
tolerance for high levels of catecholamines [8]. 
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       Once diagnosis of a pheochromocytoma is made, options 
for treatment can then be discussed.  Care is aimed at 
managing catecholamine excess and surges, in order to 
prevent hypertensive emergency and damaging 
cardiovascular effects.  Alpha- and beta-adrenergic blockers 
are commonly prescribed.  Titration of these vasoconstrictors 
is often performed on an inpatient unit for tighter control. 
Ultimately, if the patient is a candidate, surgical removal of 
the pheochromocytoma is the best treatment option.  Surgery 
can be performed through a laparoscopic approach or by 
open incision adrenalectomy.  Risk factors are reviewed to 
determine the most appropriate procedure.  These include 
tumor size, patient age, body mass index, and known 
anesthesia complications [2].  Vital signs are closely 
monitored and controlled, before, during and after the 
procedure [3].  Surgery alone is often a cure, although 
chemotherapy may accompany the post-surgical regimen at 
times.   
     Although rare, a pheochromocytoma can lead to devastating, 
even fatal outcomes.  Excessive epinepherine and 
norepinepherine surges often cause dangerous hypertension 
and cardiac decline.  Understanding the pathophysiology 
involved will enable the advance practice nurse to consider this 
tumor as as part of the differential diagnoses. She can recognize 
symptoms, aid in diagnosing early, and monitor potentially life-
threatening conditions closely.  Treatment includes lab data 
collection, anti-hypertensive medication evaluation, monitoring  
of vital signs, and pre- and post-surgical care.  Patient education 
regarding pheochromocytoma is key to patient success. 
     The informed nurse can be of great importance when 
diagnosing the cause of hypertension.  By obtaining a detailed 
history of both chronic and intermittent symptoms, a pattern 
can be established.  This pattern is vital when considering a 
diagnosis of a pheochromocytoma.  Once diagnosed, the nurse 
must educate the patient regarding symptoms, emphasizing the 
importance of early recognition and when to seek immediate 
care .  Stress reduction and lifestyle modification are important 
treatment modalities.  Nurses need to teach their patients 
regarding the effect of weight management, diet and exercise, 
and non-smoking on healthier outcomes.  Evaluating vital signs, 
medication effectiveness, reporting important findings to the 
physician, monitoring glucose levels, and assisting with pain 
control are all important nursing responsibilities, both prior to 
and following surgery.   
     Hypertension is an extremely common diagnosis today.  This condition can be caused by a multitude 
of factors, and can inversely cause numerous unfavorable processes in the body.  One rare but 
significant source of hypertension is a tumor known as a pheochromocytoma, or PCC.   
     This usually benign tumor is most often located on an adrenal gland, and can have a grave impact on 
the cardiovascular system.   The tumor intermittently secretes an excess of the catecholamine 
norepinephrine, and if large enough, also secretes epinephrine [9].  These episodic bursts can cause 
extreme hypertension and tachycardia, leading to, at times fatal results.  By understanding the 
pathophysiology and clinical presentation of a pheochromocytoma, this tumor can be considered as part 
of the early differential diagnoses by the advanced practice nurse.  If a detailed history is obtained, the 
PCC patient can be treated appropriately and a potentially tragic outcome may be avoided.  Surgical 
intervention is the most successful treatment modality, if the patient has been deemed a good candidate 
[3].  Careful monitoring must be performed pre-, during, and after surgery, noting any changes in vital 
signs or mental status.  Pertinent patient education must be provided regarding significant symptoms, 
lifestyle modifications and when to seek immediate medical attention. 
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Diagnosis  
                                 
Radiologic image of a pheochromocytoma [10]       
     A diagnosis of PCC is made base on increased serum and urine 
catecholamine and catecholamine metabolite levels.  Plasma free 
metenephrine measuring, done by immunoassay, has been declared 
more sensitive and accurate than measuring urine catecholamine 
levels. Positive levels are considered those over 90 ng/L and 125 
nmol/day, respectively [6]. Unfortunately, many false-positive test 
results occur related to the low number of patients inflicted with a 
tumor of this sort. Elevated results also do not distinguish between 
the presence of a pheochromocytoma or a paraganglioma. Hence, 
once critical levels are identified, radiological studies, such as cat 
scan and magnetic resonance imaging, are then performed to 
confirm location and size [6].   
Resected pheochromocytoma [7] 
     Although difficult to assess accurately, malignancy is 
suspected in up to ten percent of pheochromocytoma cases.  
Without metatastasis, survival rate five years post-diagnosis is 
as high as eighty-nine percent.  This percentage decreases 
drastically as metastasis is involved.  Presently studies exist that 
are aimed at identifying  genetic components and mutations, 
although on a large scale, these studies remain a challenge 
because the tumor is so rare [8]. 
